Nature (RSS/Atom feed) on Nostr: Why pharma firms are betting billions on psychedelic drugs despite setbacks Nature, ...

Why pharma firms are betting billions on psychedelic drugs despite setbacks

Nature, Published online: 27 October 2026; [doi:10.1038/d41586-026-03390-8][1]

Regulatory pushback stalled the field. But researchers are optimistic about mind-altering drugs as potential treatments for depression and mood disorders.

[1]: https://www.nature.com/articles/d41586-026-03390-8


https://www.nature.com/articles/d41586-026-03390-8